Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Corinne Levy

Showing results (1-10 of 162) with videos related to

Pageof 17
Sort By:
Human Vaccines & Immunotherapeutics|February 25, 2016
The multifaceted impact of pneumococcal conjugate vaccine implementation in children in France between 2001 to 2014Robert Cohen, Sandra Biscardi, Corinne Levy
Infectious Diseases Now|June 14, 2024
The latest news in France before distribution of third-generation pneumococcal conjugate vaccinesRobert Cohen, Corinne Levy, Emmanuelle Varon
Paediatric Drugs|August 22, 2013
Impact of pneumococcal conjugate vaccines on microbial epidemiology and clinical outcomes of acute otitis mediaIsabelle Hau, Corinne Levy, Laurence Caeymaex, et al.
Acta Paediatrica (Oslo, Norway : 1992)|May 6, 2026
Thirty Years of Pneumococcal Conjugate Vaccines in Children: Achievements, Challenges and Lessons From a Moving TargetRobert Cohen, Corinne Levy, André Birgy, et al.
Expert Review of Vaccines|April 15, 2017
Impact of pneumococcal conjugate vaccines for children in high- and non-high-income countriesRobert Cohen, Jérémie François Cohen, Martin Chalumeau, et al.
Vaccine|October 18, 2015
Invasive disease potential of pneumococci before and after the 13-valent pneumococcal conjugate vaccine implementation in childrenEmmanuelle Varon, Robert Cohen, Stéphane Béchet, et al.
Vaccine|September 6, 2016
Comparative impact of pneumococcal conjugate vaccines on pneumococcal meningitis according to underlying conditionsRobert Cohen, Emmanuelle Varon, Stéphane Béchet, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 15, 2019
Changes in Invasive Pneumococcal Disease Spectrum After 13-Valent Pneumococcal Conjugate Vaccine ImplementationCorinne Levy, Emmanuelle Varon, Naim Ouldali, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 27, 2024
Impact of C-reactive protein point-of-care testing on antibiotic prescriptions for children and adults with suspected respiratory tract infections in primary care: a French patient-level randomized controlled superiority trialCamille Jung, Corinne Levy, Stéphane Béchet, et al.
Acta Paediatrica (Oslo, Norway : 1992)|May 17, 2017
Case-control study shows that neonatal pneumococcal meningitis cannot be distinguished from group B Streptococcus casesAlexandra Arfi, Robert Cohen, Emmanuelle Varon, et al.
Pageof 17

Showing results (1-10 of 162) with videos related to

Sort By:
Pageof 17
Human Vaccines & Immunotherapeutics|February 25, 2016
The multifaceted impact of pneumococcal conjugate vaccine implementation in children in France between 2001 to 2014Robert Cohen, Sandra Biscardi, Corinne Levy
Infectious Diseases Now|June 14, 2024
The latest news in France before distribution of third-generation pneumococcal conjugate vaccinesRobert Cohen, Corinne Levy, Emmanuelle Varon
Paediatric Drugs|August 22, 2013
Impact of pneumococcal conjugate vaccines on microbial epidemiology and clinical outcomes of acute otitis mediaIsabelle Hau, Corinne Levy, Laurence Caeymaex, et al.
Acta Paediatrica (Oslo, Norway : 1992)|May 6, 2026
Thirty Years of Pneumococcal Conjugate Vaccines in Children: Achievements, Challenges and Lessons From a Moving TargetRobert Cohen, Corinne Levy, André Birgy, et al.
Expert Review of Vaccines|April 15, 2017
Impact of pneumococcal conjugate vaccines for children in high- and non-high-income countriesRobert Cohen, Jérémie François Cohen, Martin Chalumeau, et al.
Vaccine|October 18, 2015
Invasive disease potential of pneumococci before and after the 13-valent pneumococcal conjugate vaccine implementation in childrenEmmanuelle Varon, Robert Cohen, Stéphane Béchet, et al.
Vaccine|September 6, 2016
Comparative impact of pneumococcal conjugate vaccines on pneumococcal meningitis according to underlying conditionsRobert Cohen, Emmanuelle Varon, Stéphane Béchet, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 15, 2019
Changes in Invasive Pneumococcal Disease Spectrum After 13-Valent Pneumococcal Conjugate Vaccine ImplementationCorinne Levy, Emmanuelle Varon, Naim Ouldali, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 27, 2024
Impact of C-reactive protein point-of-care testing on antibiotic prescriptions for children and adults with suspected respiratory tract infections in primary care: a French patient-level randomized controlled superiority trialCamille Jung, Corinne Levy, Stéphane Béchet, et al.
Acta Paediatrica (Oslo, Norway : 1992)|May 17, 2017
Case-control study shows that neonatal pneumococcal meningitis cannot be distinguished from group B Streptococcus casesAlexandra Arfi, Robert Cohen, Emmanuelle Varon, et al.
Pageof 17